Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice

Cell Transplantation

Volumn 20, Issue 9, 2011, Pages 1343-1349

  Suarez Pinzon, Wilma L ^a   Rabinovitch, Alex ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Gastrin; Gastrointestinal hormones; Glucagon like peptide 1; Islet cell; Pancreas endocrine; Type 1 diabetes

Indexed keywords

C PEPTIDE; GASTRIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; PANTOPRAZOLE; SITAGLIPTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SCID MOUSE; TREATMENT OUTCOME;

ADULT; ANIMALS; CELL TRANSPLANTATION; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MICE; MICE, INBRED NOD; MICE, SCID; ORGANOGENESIS; PANCREATIC DUCTS; PROTON PUMP INHIBITORS;

MUS;

EID: 79960714565     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X557263     Document Type: Article

References (19)

1. Drucker D. J.; Nauck M. A. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705; 2006.
2. Elsner M.; Tiedge M.; Lenzen S. Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan. Diabetologia 46:1713-1714; 2003.
3. Hao E.; Tyrberg B.; Itkin-Ansari P.; Lakey J. R. T.; Geron I.; Monosov E. Z.; Barcova M.; Mercola M.; Levine F. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat. Med. 12:310-316; 2006.
4. Kieffer T. J.; McIntosh C. H.; Pederson R. A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136:3585-3596; 1995.
5. Kim S. J.; Nian C.; McIntosh C. H. S. Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and-independent pathways. Diabetes 59:1739-1750; 2010.
6. Lakey J. R.; Warnock G. L.; Shapiro A. M.; Korbutt G. S.; Ao Z.; Kneteman N. M.; Rajotte R. V. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 8:285-292; 1999.
7. Martin-Pagola A.; Sisino G.; Allende G.; Dominguez-Bendala J.; Gianani R.; Reijonen H.; Nepom G. T.; Ricordi C.; Ruiz P.; Sageshima J.; Ciancio G.; Burke G. W.; Pugliese A. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia 51:1803-1813; 2008.
8. Mayhew C. N.; Wells J. M. Converting human pluripotent stem cells into β-cells: Recent advances and future challenges. Curr. Opin. Organ Transplant. 15:54-60; 2010.
9. Mu J.; Woods J.; Zhou Y. P.; Roy R. S.; Li Z.; Zycband E.; Feng Y.; Zhu L.; Li C.; Howard A. D.; Moller D. E.; Thornberry N. A.; Zhang B. B. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55:1695-1704; 2006.
10. Noguchi H.; Naziruddin B.; Jackson A.; Shimoda M.; Ikemoto T.; Fujita Y.; Chujo D.; Takita M.; Kobayashi N.; Onaca N.; Hayashi S.; Levy M. F.; Matsumoto S. Characterization of human pancreatic progenitor cells. Cell Transplant. 19:879-886; 2010.
11. Pospisilik J. A.; Martin J.; Doty T.; Ehses J.; Pamir N.; Lynn F.; Piteau S.; Demuth H. U.; McIntosh C.; Pederson R. Dipeptidyl peptidase IV inhibitor treatment stimulates beta cell survival and islet neogenesis in streptozotocin induced diabetic rats. Diabetes 52:741-750; 2003.
12. Rooman I.; Lardon J.; Bouwens L. Gastrin stimulates β-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreatic tissue. Diabetes 51:686-690; 2002.
13. Suarez-Pinzon W. L.; Cembrowski G. S.; Rabinovitch A. Combination therapy with a dipeptidyl peptide-1 inhibitor and a proton pump inhibitor restores normoglycemia in non-obese diabetic mice. Diabetologia 52:1680-1682; 2009.
14. Suarez-Pinzon W. L.; Lakey J. R. T.; Rabinovitch A. Combination therapy with glucagon-like peptide-1 and gastrin induces β-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant. 17:631-640; 2008.
15. Suarez-Pinzon W. L.; Power R. F.; Yan Y.; Wasserfall C.; Atkinson M.; Rabinovitch A. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57:3281-3288; 2008.
16. Tian L.; Gao J.; Hao J.; Ziang Y.; Yi H.; O'Brien T. D.; Sorenson R.; Luo J.; Guo Z. Reversal of new-onset diabetes through modulating inflammation and stimulating β-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Endocrinology 151:3049-3060; 2010.
17. Wang T.; Singh B.; Warnock G.; Rajotte R. V. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114-117; 1992.
18. Wang T. C.; Bonner-Weir S.; Oates P. S.; Chulak M.; Simon B.; Merlino G. T.; Schmidt E. V.; Brand S. J. Pancreatic gastrin stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells. J. Clin. Invest. 92:1349-1356; 1993.
19. Yatoh S.; Dodge R.; Akashi T.; Omer A.; Sharma A.; Weir G. C.; Bonner-Weir S. Differentiation of affinity-purified human pancreatic duct cells to β-cells. Diabetes 56:1802-1809; 2007.